Field Trip Health Ltd. Common Shares to Trade on the OTCQX Best Market Post published:January 28, 2021 Post category:Press Release
Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland Post published:January 28, 2021 Post category:Press Release
BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA IND-enabling Pharmacology Studies Post published:January 28, 2021 Post category:Press Release
Mydecine Innovations Group Files Application to list to the NASDAQ Post published:January 27, 2021 Post category:Press Release
NeonMind Appoints Robert Tessarolo as President and Chief Executive Officer Post published:January 27, 2021 Post category:Press Release
UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition Post published:January 27, 2021 Post category:Analysis/News
Psyence Group to Commence Trading (CSE:PSYG) on January 27, 2021 Post published:January 26, 2021 Post category:Press Release
atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents Post published:January 26, 2021 Post category:Press Release
Novamind Announces Marketing Services Agreements Post published:January 26, 2021 Post category:Press Release
MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category Post published:January 26, 2021 Post category:Press Release